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Abstract: Pleuropneumonia is one of the most important bacterial diseases of the respiratory tract of the pig and 
occurs in most pig-keeping countries (2, 4, 5). Its importance derives from the fact that it can cause pneumonia 
that results in death, clinical disease may become chronic or subclinical disease in successive batches of pigs and 
can causes losses from death, reduced production, and increased costs of medication or vaccination. 
The goal of our research was to compare the following two vaccines used to prevent pig 
pleuropneumonia: 
- an inactivate autovaccine, adjuvantated produced by us, representing bacterine group 
- a subunit vaccine (Porcilis®APP) produced by Intervet, Holand, different by the first vaccine through 
composition. It contains only the antigenical factors involved in pathogenesis – purified toxins 
(capsular polysaccharides and lypopolysaccharides) and outer membrane proteins (OMP).  
 
MATERIALS AND METHODS 
 
Two groups of young pigs (between 2 and 3 weeks of age) are studied. These pigs 
(Landrace – Big White hybrid) belong to a farm in which pig pleuropneumonia with 
Actinobacillus pleuropneumoniae are endemic. The vaccination against this disease is not 
included in vaccination schedule.  
For experimental immunizations are used the follow vaccines: 
• PORCILIS®APP ACTINOPORC (INTERVET, HOLAND) 
This vaccine contains an outer membrane protein (OMP) and three toxoids (ApxI, ApxII 
and ApxII) produce by A. pleuropneumoniae. Every dose contains 50 units of OMP, 50 units 
ApxI, 25-78 units ApxII and 50 units ApxIII. Antigens are suspended in an aqua adjuvant and 
inactivated with formaline 0.02% (6). Each animal was vaccinated with 2 ml by deep 
intramuscular injection behind the ear at week 6 and week 10.  
 
• THE AUTOVACCINE (BACTERINE TYPE) 
To obtain this vaccine, we used an intense hemolytic A. pleuropneumoniae strain 
isolated from a pig pleuropneumonia outbreak. It was cultivated in BHI broth 18 hours at 
37ºC and after that it was added 10% formaline to obtain the final concentration 3‰. The tube 
was maintained 30 minutes at room temperature. As adjuvant we used alum 2%. 
Administration and doses: 2 ml by deep intramuscular injection behind the ear, twice at 19 
days interval.  
Evaluation of the immune response was made by indirect ELISA with CIVTEST suis 
APP (Laboratories HIPRA, Spain). 
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RESULTS AND DISCUSIONS 
 
The results obtained after the serum titration in day 0, 19, 30, 47, and 61 are presented in 
the next tables. 
Table 1 
Serum titration results in Porcilis®APP vaccinated group 
day 0 day 19 day 30 day 47 day 61 Serum no. 
O.D. 
1 0,165 0,654 0,516 0,587 0,664 
2 0,228 0,525 0,530 0,431 0,347 
3 0,259 0,691 0,427 0,625 0,704 
4 0,276 0,374 0,270 0,926 0,482 
5 0,370 0,492 0,329 0,450 0,424 
6 0,397 0,265 0,321 0,651 0,451 
7 0,465 0,432 0,387 0,479 0,453 
8 0,276 0,598 0,276 0,588 0,627 
9 0,186 0,386 0,379 0,600 0,589 
10 0,247 0,276 0,397 0,535 0,390 
O.D. mean 0,287 0,469 0,383 0,587 0,513 
 
After the first vaccination with Porcilis®APP in day 0 it could be observed an increase 
of the antibodies titers, so, after 3 weeks after vaccination these are 0.426 O.D. In the next 11 
days, antidodies titers decreased, still remaining at higher values from the beginning. The 
mean of antibodies titers after the second vaccination (day 30) was 0.587 O.D.  
O.D. values decrease slowly in the next 11 days, but are still in protective limits. Our 
results are the same with others (1, 3) which used this vaccine in farms with endemic 
evolution of pig pleuropneumonia. Nevertheless other Australian researches observed that 
Porcilis®APP are not useful against serotype 15 of A. pleuropneumoniae frequently isolated 
in Australia. Serotype 15 has different antigens than those antigens contains in vaccine. 
In pigs vaccinated with autovaccine (table 2) produced by us it could be observed that 
after 19 days after the first antigenic stimulus, mean of the antibodies titers increased 
insignificantly (p>0,05) register a value of 0.356 O.D. 
Table 2 
Serum titration results in autovaccine vaccinated group 
day 0 day 19 day 30 day 47 day 61 Serum no. 
O.D. 
1 0,171 0,270 0,387 0,474 0,671 
2 0,230 0,377 0,192 0,526 0,436 
3 0,356 0,494 0,325 0,430 0,475 
4 0,291 0,362 0,408 0,731 0,358 
5 0,288 0,177 0,357 0,530 0,867 
6 0,282 0,542 0,201 0,486 0,699 
7 0,400 0,279 0,189 0,689 0,516 
8 0,234 0,426 0,249 0,420 0,467 
9 0,366 0,275 0,242 0,352 0,527 
10 0,364 0,359 0,315 0,381 0,473 
O.D. mean 0,298 0,356 0,287 0,502 0,549 
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After the second vaccination, in day 19 from the first immune stimulus, O.D. values 
decreased first at 0.287 and after two weeks increased significantly (0.502 O.D.) and the last 
serum presents high titers (0.549 O.D.). 
Comparing the results obtained in Porcilis® APP vaccinated pigs with results obtained 
in group vaccinated with autovaccine (graph 1) it observed that are similarly as antibpdies 
titers dynamic, even if these two vaccines are different as type and vaccination schedule.  
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Graph 1. Comparative remarks about antibodies titers dynamic in the vaccinated groups 
 
Comparative research on immunogenity of some vaccines against pig pleuropneumonia 
showed that all tested vaccines are immunogene, but not in equal proportion and determine 
significant increases (p<0,01) of antibody titers during the observation period. 
The inactivated and adjuvantated vaccine, prepared by us from a virulent strain isolated 
from a disease center induced a moderate increase of titers after the first antigenic stimulus 
(O.D.=0.356) and with a significant increase of titers (O.D.=0.502) starting  the 11th day from 
the second stimulus and maintaining at high levels until the end of the two month observation 
period. 
Considering the results presented in the last chapter concerning the immunological 
efficiency, we can say that the best ELISA titers were obtained, in order, with the vaccine 
Porcilis®APP (Intervet, Holland) and inactivated autovaccine with alum as adjuvant.  
Comparative research on immunogenity of some vaccines against pig pleuropneumonia 
showed that all the four tested vaccines are immunogene, but not in equal proportion and 
determine significant increases (p<0,01) of antibody titers during the observation period. 
 
CONCLUSIONS 
 
The obtained results in the two vaccinated groups, allows the following conclusions: 
 
 The subunit vaccine Porcilis®APP administered to piglets in two rounds, at 30 days 
interval, determined a moderate increase of mean antibody titers at 19 days from the first 
administration and a significant increase of antibody titers after the second vaccination. 
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 The inactivated and adjuvantated vaccine, prepared by us from a virulent strain isolated 
from a disease center induced a moderate increase of titers after the first antigenic 
stimulus (O.D.=0.356) and with a significant increase of titers (O.D.=0.502) starting  the 
11th day from the second stimulus and maintaining at high levels until the end of the two 
month observation period. 
 
 The two vaccines, belonging at two different classes, with different administration 
schedules, induced alike dynamics of antibodies titers. Immunological effect was strong in 
Porcilis® APP vaccine. 
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